Page 74 - 2020 ASCO-GU Canadian Ambassador Program
P. 74
ASCO-GU 2020
Abstract 15: Pembrolizumab (pembro) plus enzalutamide
(enza) for enza-resistant metastatic castration-resistant
prostate cancer (mCRPC): KEYNOTE-199 cohorts 4-5
First Author: Dr. Julie Nicole Graff, MD
